AMOLYT PHARMA

Amolyt Pharma specializes in peptides for the treatment of rare endocrine and metabolic disorders. Its programs include AZP-3601, a parathyroid hormone analog, for the potential treatment of hypoparathyroidism, and AZP-3404, a peptide with a new and unique mechanism of action, that may restore fat and glucose metabolism.

#SimilarOrganizations #People #Financial #Event #Website #More

AMOLYT PHARMA

Social Links:

Linkedin

Twitter

Industry:

Biotechnology Health Care Medical Pharmaceutical Therapeutics Wellness

Founded:

2007-01-01

Address:

Écully, Rhone-Alpes, France

Country:

France

Website Url:

http://www.amolytpharma.com

Total Employee:

11+

Status:

Active

Contact:

33 4 72 18 94 28

Email Addresses:

[email protected]

Total Funding:

172.65 M USD

Technology used in webpage:

Google Analytics Google Tag Manager WordPress Nginx PHP Typekit Elementor Matomo Astra

Similar Organizations

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

dvmo-logo

DVMO

DVMO specializes in the care and therapy of patients with chronic and traumatic wounds.

forendo-pharma-logo

Forendo Pharma

Forendo Pharma is a developer of novel drugs intended for the treatment of urological and other endocrinological diseases.

passage-bio-logo

Passage Bio

Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.

the-ophthalmologist-logo

The ophthalmologist

The ophthalmologist is an eye clinic for the treatment of medical and surgical eye disease.

Current Advisors List

roy-amariglio_image

Roy Amariglio Board Member @ Amolyt Pharma
Board_member

naveed-siddiqi_image

Naveed Siddiqi Board Member @ Amolyt Pharma
Board_member

thierry-laugel_image

Thierry Laugel Board Member @ Amolyt Pharma
Board_member

felice-verduyn_image

Felice Verduyn Board Member @ Amolyt Pharma
Board_member

iyona-rajkomar_image

Iyona Rajkomar Board Member @ Amolyt Pharma
Board_member

Current Employees Featured

mark-sumeray_image

Mark Sumeray
Mark Sumeray Chief Medical Officer @ Amolyt Pharma
Chief Medical Officer
2022-05-01

thierry-abribat_image

Thierry Abribat
Thierry Abribat Founder & CEO @ Amolyt Pharma
Founder & CEO
2015-01-01

Founder

thierry-abribat_image

Thierry Abribat

Investors List

mass-general-brigham-ventures_image

Mass General Brigham Ventures

Mass General Brigham Ventures investment in Series B - Amolyt Pharma

novo-ventures_image

Novo Ventures

Novo Ventures investment in Series B - Amolyt Pharma

pontifax_image

Pontifax

Pontifax investment in Series B - Amolyt Pharma

orbimed-advisors_image

OrbiMed

OrbiMed investment in Series B - Amolyt Pharma

eurazeo-com_image

Eurazeo

Eurazeo investment in Series B - Amolyt Pharma

kurma-life-science-partners_image

Kurma Partners

Kurma Partners investment in Series B - Amolyt Pharma

sham-innovation-santé_image

Sham Innovation Santé

Sham Innovation Santé investment in Series B - Amolyt Pharma

atem-capital_image

ATEM Capital Fund LP

ATEM Capital Fund LP investment in Series B - Amolyt Pharma

credit-agricole-entreprises_image

Credit Agricole Entreprises

Credit Agricole Entreprises investment in Series B - Amolyt Pharma

life-sciences-partners_image

Life Sciences Partners

Life Sciences Partners investment in Series B - Amolyt Pharma

Key Employee Changes

Date	New article
2022-06-29	Amolyt Pharma Strengthens Leadership Team with Appointment of Mark Sumeray, M.D., as Chief Medical Officer

Official Site Inspections

http://www.amolytpharma.com Semrush global rank: 3.64 M Semrush visits lastest month: 3.9 K

Host Informations
Whois Informations

Loading ...

More informations about "Amolyt Pharma" on Search Engine